November 30, 2020:
Sigma 1 receptor in treatment for neurodegenerative diseases.
https://www.tandfonline.com/doi/full/10.1080/17460441.2021.1838483?scroll=top&needAccess=true
November 30, 2020:
Sigma 1 receptor in treatment for neurodegenerative diseases.
https://www.tandfonline.com/doi/full/10.1080/17460441.2021.1838483?scroll=top&needAccess=true
Publication: American Society of Neuroradiology | Publication Date: October 29, 2020
Authors: A. Samara, H.M. Lugar, T. Hershey, and J.S. Shimony
Wolfram syndrome is a rare genetic disease with characteristic brain involvement. We reviewed the brain MR images of patients with Wolfram syndrome to determine the frequency and characteristics of common neuroradiologic findings
Publication: MDPI.org | Publication Date: August 4, 2020
Authors: Arleta Waszczykowska, Agnieszka Zmyslowska, Marcin Braun, Marilin Ivask, Sulev Koks, Piotr Jurowski, and Wojciech Mylnarski
To investigate retinal thickness and wolframin expression disorders in Wolfram syndrome 1 gene knockout (Wfs1KO) mice compared to their wild-type (WT) littermates.
Publication: American Diabetes Association | Publication Date: June 2020
Authors: Mary Katherine Ray, Tamara Hershey, Ling Chen, Neil H. White, and Bess A. Marshall
The purpose of this study was to examine progression of DM, measured by beta-cell function, in WFS patients over time. N=44 (25F/19M) participants with genetically confirmed WFS attended the Washington University Wolfram Research Clinic from 2010-2019.
Publication: Endocrine-abstracts.org | Publication Date: May 23, 2020
Authors: Mouna Sghir, Soumaya Elarem, Wafa Said, Aymen Haj Salah, Baha Zantour & Wassia Kessomtini
Wolfram syndrome (WS) is an autosomal recessive neurodegenerative disorder characterized by Diabetes Insipidus, Diabetes Mellitus (non-autoimmune), Optic Atrophy, and Deafness. We report the case of a patient sent to the physical and rehabilitation department to manage urinary disorders and for whom the diagnosis of WS was retained.
November 23, 2020:
A case report filing a Wolfram Syndrome diagnosis of a woman with a urinary disorder.
November 19, 2020:
The evolution of gene therapy.
https://www.genengnews.com/insights/gene-therapys-renaissance/
November 17, 2020:
The use of an artificial pancreas in diabetes treatment.
https://vpm.org/articles/17057/how-can-an-artificial-pancreas-help-fight-diabetes
November 15, 2020:
The relationship of the neuroinflammatory mechanism of glaucomatous neurodegeneration and the administration of NLY01.
https://www.cell.com/cell-reports/fulltext/S2211-1247%2820%2931260-2
The Snow Foundation is a collective voice for Wolfram syndrome patients, working towards a cure for Wolfram syndrome and developing novel therapies for diabetes, vision loss, hearing loss and neurodegeneration.
P.O. Box 50224 Clayton, MO 63105
(402) 694-1354
You must be logged in to post a comment.